Subtopic Deep Dive
Apelin in Cardiovascular Regulation
Research Guide
What is Apelin in Cardiovascular Regulation?
Apelin in cardiovascular regulation refers to the role of apelin peptide and its APJ receptor in modulating blood pressure, vascular tone, and cardiac contractility via G-protein coupled signaling pathways.
Apelin exhibits vasodepressor effects and positive inotropic actions on the heart through APJ activation (Chun et al., 2008; 324 citations). Apelin gene-deficient mice show impaired heart contractility under aging and pressure overload (Kuba et al., 2007; 294 citations). The APJ receptor regulates homeostasis including cardiovascular function (O’Carroll et al., 2013; 323 citations). Over 1,500 papers explore apelin-APJ in cardiovascular contexts.
Why It Matters
Apelin-APJ signaling antagonizes angiotensin II effects in atherosclerosis models, reducing vascular inflammation and improving endothelial function (Chun et al., 2008). In heart failure, apelin deficiency impairs contractility, suggesting therapeutic potential for hypertension and cardiac remodeling (Kuba et al., 2007). Apelin modulates obesity-linked cardiovascular risks via adipose tissue secretion (Wang and Nakayama, 2010). These mechanisms support novel treatments for cardiovascular diseases, leading global mortality causes.
Key Research Challenges
Translating Mouse Model Findings
Apelin knockout mice exhibit impaired cardiac contractility under pressure overload, but human translation remains limited (Kuba et al., 2007). Species differences in APJ signaling pathways complicate clinical applicability (O’Carroll et al., 2013). Validating hypotensive effects requires advanced human models.
APJ Pathway Specificity
Apelin-APJ opposes Ang II in atherosclerosis but interacts with multiple G-proteins, risking off-target effects (Chun et al., 2008). Balancing vasodepressor and inotropic actions needs precise receptor modulation (O’Carroll et al., 2013). Signaling crosstalk challenges selective agonism.
Therapeutic Delivery Barriers
Short apelin half-life limits sustained cardiovascular benefits in hypertension models (Kuba et al., 2007). Endothelial targeting in diseased vessels faces delivery inefficiencies (Chun et al., 2008). Developing stable APJ agonists requires overcoming peptide degradation.
Essential Papers
Inflammation, a Link between Obesity and Cardiovascular Disease
Zhaoxia Wang, Tomohiro Nakayama · 2010 · Mediators of Inflammation · 411 citations
Obesity, the most common nutritional disorder in industrialized countries, is associated with an increased mortality and morbidity of cardiovascular disease (CVD). Obesity is primarily considered t...
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis
Hyung J. Chun, Ziad A. Ali, Yoko Kojima et al. · 2008 · Journal of Clinical Investigation · 324 citations
Apelin and its cognate G protein-coupled receptor APJ constitute a signaling pathway with a positive inotropic effect on cardiac function and a vasodepressor function in the systemic circulation. T...
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
Anne‐Marie O’Carroll, Stephen J. Lolait, Louise E. Harris et al. · 2013 · Journal of Endocrinology · 323 citations
The apelin receptor (APJ; gene symbol APLNR ) is a member of the G protein-coupled receptor gene family. Neural gene expression patterns of APJ, and its cognate ligand apelin, in the brain implicat...
Impaired Heart Contractility in Apelin Gene–Deficient Mice Associated With Aging and Pressure Overload
Keiji Kuba, Liyong Zhang, Yumiko Imai et al. · 2007 · Circulation Research · 294 citations
Apelin constitutes a novel endogenous peptide system suggested to be involved in a broad range of physiological functions, including cardiovascular function, heart development, control of fluid hom...
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
Lucie Geurts, Audrey M. Neyrinck, Nathalie M. Delzenne et al. · 2013 · Beneficial Microbes · 277 citations
Crosstalk between organs is crucial for controlling numerous homeostatic systems (e.g. energy balance, glucose metabolism and immunity). Several pathological conditions, such as obesity and type 2 ...
Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis
Hiroyasu Kidoya, Masaya Ueno, Yoshihiro Yamada et al. · 2008 · The EMBO Journal · 262 citations
Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
Yili Wu, Xin Wang, Xuan Zhou et al. · 2017 · Frontiers in Molecular Neuroscience · 256 citations
Stroke is one of the leading causes of death and disability worldwide, and ischemic stroke accounts for approximately 87% of cases. Improving post-stroke recovery is a major challenge in stroke tre...
Reading Guide
Foundational Papers
Start with Chun et al. (2008; 324 citations) for apelin-APJ vasodepressor effects in atherosclerosis; Kuba et al. (2007; 294 citations) for contractility in knockouts; O’Carroll et al. (2013; 323 citations) for receptor overview.
Recent Advances
Wysocka et al. (2018; 244 citations) reviews apelin in cardiovascular diseases; Recinella et al. (2020; 244 citations) covers adipokine roles.
Core Methods
G-protein coupled APJ signaling assays; apelin-deficient mouse models under pressure overload; Ang II co-administration in vascular studies.
How PapersFlow Helps You Research Apelin in Cardiovascular Regulation
Discover & Search
Research Agent uses searchPapers with query 'apelin APJ cardiovascular regulation' to retrieve 50+ papers including Chun et al. (2008; 324 citations), then citationGraph maps APJ signaling networks, and findSimilarPapers expands to related hypertension studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Chun et al. (2008) to extract mouse atherosclerosis data, verifyResponse with CoVe checks apelin's vasodepressor claims against Kuba et al. (2007), and runPythonAnalysis performs statistical verification of contractility metrics using pandas for correlation analysis; GRADE grading scores evidence as high for mouse models.
Synthesize & Write
Synthesis Agent detects gaps in human trials via contradiction flagging between mouse data (Kuba et al., 2007) and clinical needs, then Writing Agent uses latexEditText for drafting reviews, latexSyncCitations for 20+ apelin papers, and latexCompile for publication-ready manuscripts with exportMermaid diagrams of APJ-GPCR pathways.
Use Cases
"Extract contractility data from apelin knockout studies and plot age-related decline."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Kuba et al., 2007) → runPythonAnalysis (pandas/matplotlib plots heart function curves) → researcher gets CSV-exported decline graphs with stats.
"Draft LaTeX review on apelin-APJ in hypertension therapies."
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections) → latexSyncCitations (Chun/Kuba papers) → latexCompile → researcher gets compiled PDF with synced bibliography.
"Find GitHub repos analyzing apelin signaling datasets."
Research Agent → paperExtractUrls (O’Carroll et al., 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets inspected code for APJ pathway simulations.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (apelin cardiovascular) → citationGraph → DeepScan (7-step analysis of Chun et al., 2008 vs. Kuba et al., 2007) → structured report on therapeutic gaps. Theorizer generates hypotheses on APJ agonists from 30 papers via gap detection and CoVe verification. DeepScan verifies signaling claims across obesity-cardiac links (Wang and Nakayama, 2010).
Frequently Asked Questions
What defines apelin in cardiovascular regulation?
Apelin acts via APJ receptor to lower blood pressure and enhance cardiac contractility through G-protein signaling (Chun et al., 2008).
What methods study apelin-APJ cardiovascular effects?
Mouse knockout models assess contractility (Kuba et al., 2007); Ang II antagonism tests use atherosclerosis models (Chun et al., 2008).
What are key papers on this topic?
Chun et al. (2008; 324 citations) on apelin vs. Ang II; Kuba et al. (2007; 294 citations) on deficient mice; O’Carroll et al. (2013; 323 citations) on APJ homeostasis.
What open problems exist?
Human translation of mouse hypotensive effects; stable agonist development; pathway specificity in diseased endothelium (Chun et al., 2008; Kuba et al., 2007).
Research Apelin-related biomedical research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Apelin in Cardiovascular Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers